---
figid: PMC7407119__cancers-12-01706-g002
figtitle: The antioxidative landscape in the cell, and the corresponding modulators
  of key players
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC7407119
filename: cancers-12-01706-g002.jpg
figlink: pmc/articles/PMC7407119/figure/cancers-12-01706-f002/
number: F2
caption: Schematic overview of the antioxidative landscape in the cell, and the corresponding
  modulators of key players. Reactive oxygen species (ROS) activate the Nrf2–Keap1
  signalling pathway, resulting in induction of the antioxidant response elements
  (ARE) by Nrf2 in the nucleus. ARE comprise the glutathione (GSH) system, the peroxiredoxin–thioredoxin
  system, and antioxidative enzymes, such as NAD(P)H dehydrogenases [quinone], superoxide
  dismutases, and catalase. In the GSH system, the sequential activity of glutamate
  cysteine ligase (GCL) and glutathione synthetase (GSS) produces the tripeptide GSH.
  Glutathione peroxidases (GPx), which are often selenoproteins, use GSH to scavenge
  ROS, resulting in glutathione disulfide (GSSG). Glutathione reductase (GSR) regenerates
  GSH using FAD and NAD(P)H. GSH is also used for conjugation by glutathione S-transferase
  (GST) in cellular detoxification processes. In the peroxiredoxin–thioredoxin system,
  ROS are scavenged by peroxiredoxin (PRDX), resulting in oxidation of PRDX’s peroxidatic
  cysteine to sulfenic acid or disulfide bonds. Overoxidation yields sulfinic or irreversible
  sulfonic acid. Thioredoxin (TXN) and the selenoprotein thioredoxin reductase (TxR)
  regenerate PRDX using FAD and NAD(P)H. Names of pharmaceutical and experimental
  inhibitors and activators are presented, and the corresponding target sites are
  indicated by red lines or blue arrows, respectively.
papertitle: Targeting the Redox Landscape in Cancer Therapy.
reftext: Dilip Narayanan, et al. Cancers (Basel). 2020 Jul;12(7):1706.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9542359
figid_alias: PMC7407119__F2
figtype: Figure
redirect_from: /figures/PMC7407119__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7407119__cancers-12-01706-g002.html
  '@type': Dataset
  description: Schematic overview of the antioxidative landscape in the cell, and
    the corresponding modulators of key players. Reactive oxygen species (ROS) activate
    the Nrf2–Keap1 signalling pathway, resulting in induction of the antioxidant response
    elements (ARE) by Nrf2 in the nucleus. ARE comprise the glutathione (GSH) system,
    the peroxiredoxin–thioredoxin system, and antioxidative enzymes, such as NAD(P)H
    dehydrogenases [quinone], superoxide dismutases, and catalase. In the GSH system,
    the sequential activity of glutamate cysteine ligase (GCL) and glutathione synthetase
    (GSS) produces the tripeptide GSH. Glutathione peroxidases (GPx), which are often
    selenoproteins, use GSH to scavenge ROS, resulting in glutathione disulfide (GSSG).
    Glutathione reductase (GSR) regenerates GSH using FAD and NAD(P)H. GSH is also
    used for conjugation by glutathione S-transferase (GST) in cellular detoxification
    processes. In the peroxiredoxin–thioredoxin system, ROS are scavenged by peroxiredoxin
    (PRDX), resulting in oxidation of PRDX’s peroxidatic cysteine to sulfenic acid
    or disulfide bonds. Overoxidation yields sulfinic or irreversible sulfonic acid.
    Thioredoxin (TXN) and the selenoprotein thioredoxin reductase (TxR) regenerate
    PRDX using FAD and NAD(P)H. Names of pharmaceutical and experimental inhibitors
    and activators are presented, and the corresponding target sites are indicated
    by red lines or blue arrows, respectively.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Neurl4
  - gcl
  - Gclc
  - Cys
  - mmy
  - Csp
  - GstS1
  - GstE12
  - GstD1
  - GstD2
  - GstD3
  - GstD4
  - GstD5
  - GstD6
  - GstD7
  - GstD8
  - Gss1
  - Gss2
  - ry
  - PHGPx
  - Sh
  - Desat2
  - Fadd
  - Fad2
  - Desat1
  - Fancd2
  - rta
  - se
  - Keap1
  - cnc
  - norpA
  - l(3)X12
  - so
  - ato
  - Trxr-1
  - Trxr-2
  - Cat
  - GCLC
  - GCA
  - GMCL1
  - GMCL2
  - DECR1
  - SLCO6A1
  - GSTK1
  - GSTA1
  - GSTA2
  - GSTA3
  - GSTA4
  - GSTA5
  - GSTM1
  - GSTM2
  - GSTM3
  - GSTM4
  - GSTM5
  - GSTO1
  - GSTO2
  - GSTP1
  - GSTT1
  - GSTT2
  - GSTZ1
  - GSTT2B
  - GSS
  - PRNP
  - GPX1
  - GPX2
  - GPX3
  - GPX4
  - GPX5
  - GPX6
  - GPX7
  - GPX8
  - GSR
  - BRCA2
  - FANCD2
  - PSEN1
  - EPHX2
  - RBFOX2
  - MRGPRF
  - SFN
  - REXO2
  - GABPA
  - NFE2L2
  - LCS1
  - KEAP1
  - PRDX1
  - PRDX2
  - PRDX3
  - PRDX4
  - PRDX5
  - PRDX6
  - TXN
  - TXN2
  - Cibacron blue
  - Dicoumarol
  - Phenindone
  - Resveratrol
  - Glutathione
  - BSO
  - Cys
  - NADPH
  - Quinone
  - GSH
  - NAD(P)H
  - H
  - NAD
  - FADH
  - FAD
  - SeH
  - Curcumin
  - DMF
  - SFN
  - Se
  - GSSG
  - Superoxide
  - Luteolin
  - sulfonic acid O
  - ATO
  - Cisplatin
  - Auranofin
  - sulfinic acid O
  - sulfenic acid
---
